Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo

被引:100
作者
Seddon, Michael [1 ]
Melikian, Narbeh [1 ]
Dworakowski, Rafal [1 ]
Shabeeh, Husain [1 ]
Jiang, Benyu [2 ]
Byrne, Jonathan [1 ]
Casadei, Barbara [3 ]
Chowienczyk, Philip [2 ]
Shah, Ajay M. [1 ]
机构
[1] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, Dept Cardiol, London SE5 9NU, England
[2] Kings Coll London, British Heart Fdn Ctr, Dept Clin Pharmacol, London SE5 9NU, England
[3] Univ Oxford, Dept Cardiovasc Med, Oxford, England
关键词
blood flow; microcirculation; nitric oxide; vasculature; vasodilation; VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL DYSFUNCTION; SUBSTANCE-P; DEPENDENT DILATION; RISK-FACTORS; VASODILATION; HYPERTENSION; HEART; ATHEROSCLEROSIS; CIRCULATION;
D O I
10.1161/CIRCULATIONAHA.108.822205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Nitric oxide (NO)-mediated local regulation of vascular tone is considered to involve endothelial NO synthase ( eNOS). However, we recently reported that human forearm basal microvascular tone in vivo is tonically regulated by neuronal NO synthase ( nNOS), in contrast to an acetylcholine-stimulated reduction in tone, which is eNOS dependent. Here, we investigated the in vivo effects of an nNOS-selective inhibitor, S-methyl-L-thiocitrulline (SMTC), on the human coronary circulation and on flow-mediated dilatation in the forearm. Methods and Results-In patients with angiographically normal coronary arteries, intracoronary infusion of SMTC (0.625 mu mol/min) reduced basal coronary blood flow by 34.1 +/- 5.2% (n=10; P<0.01) and epicardial coronary diameter by 3.6 +/- 1.2% (P=0.02) but had no effect on increases in flow evoked by intracoronary substance P (20 pmol/min). The nonselective NOS inhibitor N-G-monomethyl-L-arginine (25 mu mol/min) also reduced basal coronary flow (by 22.3 +/- 5.3%; n=8; P<0.01) but, in contrast to SMTC, inhibited substance P-induced increases in flow (P<0.01). In healthy volunteers, local infusion of SMTC (0.2 mu mol/min) reduced radial artery blood flow by 36.0 +/- 6.4% (n=10; P=0.03) but did not affect flow-mediated dilatation (P=0.55). In contrast, N-G-monomethyl-L-arginine (2 mu mol/min) infusion reduced radial blood flow to a similar degree (by 39.7 +/- 11.8%; P=0.02) but also inhibited flow-mediated dilatation by approximate to 80% (P<0.01). Conclusions-These data indicate that local nNOS-derived NO regulates basal blood flow in the human coronary vascular bed, whereas substance P-stimulated vasodilatation is eNOS mediated. Thus, nNOS and eNOS have distinct local roles in the physiological regulation of human coronary vascular tone in vivo. (Circulation. 2009; 119: 2656-2662.)
引用
收藏
页码:2656 / 2662
页数:7
相关论文
共 35 条
  • [1] Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells -: Activation by angiotensin II in hypertension
    Boulanger, CM
    Heymes, C
    Benessiano, J
    Geske, RS
    Lévy, BI
    Vanhoutte, PM
    [J]. CIRCULATION RESEARCH, 1998, 83 (12) : 1271 - 1278
  • [2] Vascular smooth muscle and nitric oxide synthase
    Buchwalow, IB
    Podzuweit, T
    Böcker, W
    Samoilova, VE
    Thomas, S
    Wellnr, M
    Baba, HA
    Robenek, H
    Schnekenburger, J
    Lerch, MM
    [J]. FASEB JOURNAL, 2002, 16 (06) : 500 - 508
  • [3] Medical progress - Coronary microvascular dysfunction
    Camici, Paolo G.
    Crea, Filippo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 830 - 840
  • [4] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS
    CELERMAJER, DS
    SORENSEN, KE
    GOOCH, VM
    SPIEGELHALTER, DJ
    MILLER, OI
    SULLIVAN, ID
    LLOYD, JK
    DEANFIELD, JE
    [J]. LANCET, 1992, 340 (8828) : 1111 - 1115
  • [5] ENDOTHELIUM-DEPENDENT DILATION IN THE SYSTEMIC ARTERIES OF ASYMPTOMATIC SUBJECTS RELATES TO CORONARY RISK-FACTORS AND THEIR INTERACTION
    CELERMAJER, DS
    SORENSEN, KE
    BULL, C
    ROBINSON, J
    DEANFIELD, JE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (06) : 1468 - 1474
  • [6] Chilian WM, 1997, CIRCULATION, V95, P522
  • [7] SUBSTANCE-P DILATES EPICARDIAL CORONARY-ARTERIES AND INCREASES CORONARY BLOOD-FLOW IN HUMANS
    CROSSMAN, DC
    LARKIN, SW
    FULLER, RW
    DAVIES, GJ
    MASERI, A
    [J]. CIRCULATION, 1989, 80 (03) : 475 - 484
  • [8] VALIDATION OF A DOPPLER GUIDE WIRE FOR INTRAVASCULAR MEASUREMENT OF CORONARY-ARTERY FLOW VELOCITY
    DOUCETTE, JW
    CORL, PD
    PAYNE, HM
    FLYNN, AE
    GOTO, M
    NASSI, M
    SEGAL, J
    [J]. CIRCULATION, 1992, 85 (05) : 1899 - 1911
  • [9] FLOW-DEPENDENT CORONARY-ARTERY DILATATION IN HUMANS
    DREXLER, H
    ZEIHER, AM
    WOLLSCHLAGER, H
    MEINERTZ, T
    JUST, H
    BONZEL, T
    [J]. CIRCULATION, 1989, 80 (03) : 466 - 474
  • [10] Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation
    Duffy, SJ
    Castle, SF
    Harper, RW
    Meredith, IT
    [J]. CIRCULATION, 1999, 100 (19) : 1951 - 1957